BLUE logo

Bluebird Bio (BLUE) Working Capital

Annual Working Capital

$81.57 M
+$34.58 M+73.58%

31 December 2023

BLUE Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Working Capital

-$145.22 M
-$50.81 M-53.81%

30 September 2024

BLUE Quarterly Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BLUE Working Capital Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--278.0%
3 y3 years-55.5%-179.1%
5 y5 years-91.2%-115.6%

BLUE Working Capital High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-55.5%+73.6%-161.8%at low
5 y5 years-91.9%+73.6%-110.3%at low
alltimeall time-93.6%+201.2%-109.1%at low

Bluebird Bio Working Capital History

DateAnnualQuarterly
Sept 2024
-
-$145.22 M(+53.8%)
June 2024
-
-$94.41 M(+329.7%)
Mar 2024
-
-$21.97 M(-126.9%)
Dec 2023
$81.57 M(+73.6%)
$81.57 M(-7.4%)
Sept 2023
-
$88.12 M(-42.4%)
June 2023
-
$152.96 M(-34.9%)
Mar 2023
-
$235.14 M(+400.4%)
Dec 2022
$46.99 M(-74.4%)
$46.99 M(+39.4%)
Sept 2022
-
$33.71 M(+81.3%)
June 2022
-
$18.60 M(-83.4%)
Mar 2022
-
$112.03 M(-39.0%)
Dec 2021
$183.53 M(-81.9%)
$183.53 M(-67.6%)
Sept 2021
-
$565.77 M(-13.7%)
June 2021
-
$655.76 M(-26.4%)
Mar 2021
-
$891.22 M(-11.9%)
Dec 2020
$1.01 B(+9.0%)
$1.01 B(-7.7%)
Sept 2020
-
$1.10 B(-22.6%)
June 2020
-
$1.42 B(+80.9%)
Mar 2020
-
$783.04 M(-15.7%)
Dec 2019
$928.59 M(-27.0%)
$928.59 M(-9.3%)
Sept 2019
-
$1.02 B(-10.1%)
June 2019
-
$1.14 B(-6.5%)
Mar 2019
-
$1.22 B(-4.3%)
Dec 2018
$1.27 B
$1.27 B(-20.2%)
DateAnnualQuarterly
Sept 2018
-
$1.59 B(+61.1%)
June 2018
-
$989.48 M(-6.3%)
Mar 2018
-
$1.06 B(-13.9%)
Dec 2017
$1.23 B(+88.9%)
$1.23 B(+80.0%)
Sept 2017
-
$681.91 M(-34.5%)
June 2017
-
$1.04 B(+75.0%)
Mar 2017
-
$594.67 M(-8.5%)
Dec 2016
$649.68 M(+34.3%)
$649.68 M(+20.0%)
Sept 2016
-
$541.24 M(-0.2%)
June 2016
-
$542.50 M(+3.9%)
Mar 2016
-
$522.01 M(+7.9%)
Dec 2015
$483.60 M(+10.7%)
$483.60 M(-28.8%)
Sept 2015
-
$679.58 M(-13.7%)
June 2015
-
$787.42 M(+163.5%)
Mar 2015
-
$298.82 M(-31.6%)
Dec 2014
$437.01 M(+146.7%)
$437.01 M(+136.5%)
Sept 2014
-
$184.80 M(+28.9%)
June 2014
-
$143.32 M(-12.0%)
Mar 2014
-
$162.87 M(-8.0%)
Dec 2013
$177.11 M(+180.4%)
$177.11 M(-6.8%)
Sept 2013
-
$189.98 M(-5.1%)
June 2013
-
$200.17 M(+89.9%)
Mar 2013
-
$105.39 M(+66.9%)
Dec 2012
$63.16 M(+133.2%)
$63.16 M
Dec 2011
$27.09 M
-

FAQ

  • What is bluebird bio annual working capital?
  • What is the all time high annual working capital for bluebird bio?
  • What is bluebird bio quarterly working capital?
  • What is the all time high quarterly working capital for bluebird bio?
  • What is bluebird bio quarterly working capital year-on-year change?

What is bluebird bio annual working capital?

The current annual working capital of BLUE is $81.57 M

What is the all time high annual working capital for bluebird bio?

bluebird bio all-time high annual working capital is $1.27 B

What is bluebird bio quarterly working capital?

The current quarterly working capital of BLUE is -$145.22 M

What is the all time high quarterly working capital for bluebird bio?

bluebird bio all-time high quarterly working capital is $1.59 B

What is bluebird bio quarterly working capital year-on-year change?

Over the past year, BLUE quarterly working capital has changed by -$226.79 M (-278.03%)